long-acting ANP (Daiichi Sankyo)

N/A

Report date: 2025/03/20 15:46:39

Base Information

Drug Namelong-acting ANP (Daiichi Sankyo)
Drug Alias Namelong-acting atrial natriuretic peptide (Daiichi Sankyo)
ClassificationBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionAtrial natriuretic peptide receptor modulatorsAtrial natriuretic peptide receptor agonists
TargetsAtrial natriuretic peptide receptor
Therapy Area/IndicationsHypertensionHeart Failure
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryJapan
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesDaiichi Sankyo Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesDaiichi Sankyo Co Ltd
Inactive CompaniesN/A
Active IndicationsHypertensionHeart Failure
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A